bridgebio-logo

BridgeBio Pharma

BridgeBio is a company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://bridgebio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
421 Kipling St,CA-094301
Palo Alto
United States
Email
Contact Number
+1 650-391-9740

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/bridgebio” connections=”true” suffix=””]

In Jan 2019, BridgeBio Pharma, received $299.2 Mn Financing to Support Its Efforts to Target Genetic Disease at Source. The funding was co-led by its existing investors KKR and Viking Global Investors along with some others.